US Pharma MarketingThe post Jupiter Endovascular’s pulmonary embolectomy system hits primary endpoints in trial appeared first on Clinical Trials Arena.
Jupiter Endovascular’s pulmonary embolectomy system hits primary endpoints in trial
Jupiter’s Vertex uses transforming fixation, a technology designed to improve catheter navigation through the right heart into the pulmonary arteries. Jupiter’s Vertex uses transforming fixation, a technology designed to improve catheter navigation through the right heart into the pulmonary arteries. Jupiter Endovascular’s late-breaking trial data was shared at the EuroPCR 2026 congress, taking place from 19-22 May in Paris, France. Credit: Kateryna Kon / Shutterstock.com Jupiter Endovascular has shared positive pivotal trial results for its Vertex pulmonary embolectomy system in treating pulmonary embolism (PE). The 123-patient SPIRARE II trial (NCT06576427) evaluated the safety, right heart functional improvement, and clinical outcomes…
Jupiter’s Vertex uses transforming fixation, a technology designed to improve catheter navigation through the right heart into the pulmonary arteries.
Source: Clinical Trials Arena